Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (se deschide o fereastră nouă)

Brady KM, Easley RB, Tobias JD.

Sursă‎: Paediatr Anaesth 2006;16(10):1042-6.

Index‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (se deschide o fereastră nouă)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (se deschide o fereastră nouă)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Sursă‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Index‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (se deschide o fereastră nouă)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (se deschide o fereastră nouă)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Sursă‎: Pediatrics 2002;110(1 Pt 1):169-71.

Index‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (se deschide o fereastră nouă)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (se deschide o fereastră nouă)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Sursă‎: Paediatr Drugs 2017;19(1):53-8.

Index‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (se deschide o fereastră nouă)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (se deschide o fereastră nouă)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Sursă‎: J Perinatol 2011;31(3):188-92.

Index‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (se deschide o fereastră nouă)

Use of recombinant factor VIIa in infants with severe coagulopathy. (se deschide o fereastră nouă)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Sursă‎: J Perinatol 2004;24(5):310-1.

Index‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (se deschide o fereastră nouă)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (se deschide o fereastră nouă)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Sursă‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Index‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (se deschide o fereastră nouă)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (se deschide o fereastră nouă)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Sursă‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Index‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (se deschide o fereastră nouă)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (se deschide o fereastră nouă)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Sursă‎: Paediatr Anaesth 2009;19(4):364-70.

Index‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (se deschide o fereastră nouă)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (se deschide o fereastră nouă)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Sursă‎: Spine 2004;29(12):1384-7.

Index‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (se deschide o fereastră nouă)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (se deschide o fereastră nouă)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Sursă‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Index‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (se deschide o fereastră nouă)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (se deschide o fereastră nouă)

Olomu N, Kulkarni R, Manco-Johnson M.

Sursă‎: J Perinatol 2002;22(8):672-4.

Index‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (se deschide o fereastră nouă)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (se deschide o fereastră nouă)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Sursă‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Index‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (se deschide o fereastră nouă)